首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2353776篇
  免费   175918篇
  国内免费   3328篇
耳鼻咽喉   32141篇
儿科学   76187篇
妇产科学   62875篇
基础医学   349274篇
口腔科学   63999篇
临床医学   212302篇
内科学   458171篇
皮肤病学   51846篇
神经病学   186127篇
特种医学   88313篇
外国民族医学   492篇
外科学   354852篇
综合类   47677篇
现状与发展   12篇
一般理论   857篇
预防医学   183491篇
眼科学   54483篇
药学   175725篇
  9篇
中国医学   4576篇
肿瘤学   129613篇
  2021年   19110篇
  2019年   19673篇
  2018年   27207篇
  2017年   20470篇
  2016年   22878篇
  2015年   25774篇
  2014年   36311篇
  2013年   54260篇
  2012年   75124篇
  2011年   79878篇
  2010年   47313篇
  2009年   44776篇
  2008年   75071篇
  2007年   79918篇
  2006年   80727篇
  2005年   78237篇
  2004年   74815篇
  2003年   72099篇
  2002年   69738篇
  2001年   109028篇
  2000年   111736篇
  1999年   93765篇
  1998年   27136篇
  1997年   23759篇
  1996年   24155篇
  1995年   22839篇
  1994年   20993篇
  1993年   19822篇
  1992年   72234篇
  1991年   70271篇
  1990年   68621篇
  1989年   65889篇
  1988年   60508篇
  1987年   59314篇
  1986年   55394篇
  1985年   53158篇
  1984年   39433篇
  1983年   33528篇
  1982年   19945篇
  1979年   35992篇
  1978年   25749篇
  1977年   21328篇
  1976年   20447篇
  1975年   21902篇
  1974年   26252篇
  1973年   24922篇
  1972年   23305篇
  1971年   22117篇
  1970年   20340篇
  1969年   19379篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
In 1963, Goffman argued that forming a group based on shared stigma may provide benefits. However, there is no empirical research on whether perception that a separate, unique, coherent group exists (i.e., group entitativity) influences coping, such as educating others or secrecy, for the stigmatized individual or his or her spouse. Further, little is known about how spouses influence each other in terms of promoting the education of others about a stigmatizing condition, especially when it comes to the role of believing that stigma-based groups, to which they may both belong, exist. This study provides a step toward bridging this gap in the research by applying the label management model in efforts to understand coping for couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). This study included 50 married couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). We found that group entitativity related to those with AATD counterbalanced the influence of genetic stigma on spouses’ intentions to keep the diagnosis secret or to educate others about it. Intrapersonal and interpersonal influences appeared among spouses. Attention is needed on the power of creating groups for stigmatized persons and their relatives. Indeed, people live within a dynamic world of group entities, and multiple social identities including spousal and familial. While attention has been paid to the diffusion of stigmas to loved ones, less has been paid to the uplift of group entities for them.  相似文献   
132.
133.
134.
Mitochondria are known primarily as the location of the electron transport chain and energy production in cells. More recently, mitochondria have been shown to be signaling centers for apoptosis and inflammation. Reactive oxygen species (ROS) generated as by-products of the electron transport chain within mitochondria significantly impact cellular signaling pathways. Because of the toxic nature of ROS, mitochondria possess an antioxidant enzyme, superoxide dismutase 2 (SOD2), to neutralize ROS. If mitochondrial antioxidant enzymes are overwhelmed during severe infections, mitochondrial dysfunction can occur and lead to multiorgan failure or death. Pseudomonas aeruginosa is an opportunistic pathogen that can infect immunocompromised patients. Infochemicals and exotoxins associated with P. aeruginosa are capable of causing mitochondrial dysfunction. In this work, we describe the roles of SOD2 and mitochondrial ROS regulation in the zebrafish innate immune response to P. aeruginosa infection. sod2 is upregulated in mammalian macrophages and neutrophils in response to lipopolysaccharide in vitro, and sod2 knockdown in zebrafish results in an increased bacterial burden. Further investigation revealed that phagocyte numbers are compromised in Sod2-deficient zebrafish. Addition of the mitochondrion-targeted ROS-scavenging chemical MitoTEMPO rescues neutrophil numbers and reduces the bacterial burden in Sod2-deficient zebrafish. Our work highlights the importance of mitochondrial ROS regulation by SOD2 in the context of innate immunity and supports the use of mitochondrion-targeted ROS scavengers as potential adjuvant therapies during severe infections.  相似文献   
135.
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma  相似文献   
136.
137.
138.
139.
140.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号